on 20 Jun 2023
Last Applicant/ Owned by
CH-2543 Lengnau BE
CH
Serial Number
79337443 filed on 31st Jan 2022
Registration Number
7082638 registered on 20th Jun 2023
Correspondent Address
Scott D. Woldow
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
AF STYLA; ANTI-HEMOPHILIC FACTOR STYLA Pharmaceutical products for treatment of blood and coagulation disorders; blood products, namely, blood and blood plasma for medical use; blood proteins for therapeutic use; pharmaceutical blood products obtained by recombinant DNA technology for treatment of blood and coagulation disorders The mark consists of the stylized term "AFSTYLA" combined with a deRead More
Pharmaceutical products for treatment of blood and coagulation disorders; blood products, namely, blood and blood plasma for medical use; blood proteins for therapeutic use; pharmaceutical blood products obtained by recombinant DNA technology for treatment of blood and coagulation disorders
No 79337443
No Service/Collective Mark
No 034845.352
No
No
No
No
Yes
Yes
No
No
26.01.02 -
Plain single line circles
26.01.13 -
Two circles
26.01.16 -
Circles touching or intersecting
The mark consists of the stylized term "AFSTYLA" combined with a design of two intersecting circles.
| Status Date | Action Taken |
|---|---|
| 22nd Sep 2023 | FINAL DISPOSITION PROCESSED |
| 22nd Sep 2023 | FINAL DISPOSITION NOTICE SENT TO IB |
| 20th Sep 2023 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 20th Jun 2023 | REGISTERED-PRINCIPAL REGISTER |
| 20th Jun 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 04th Apr 2023 | PUBLISHED FOR OPPOSITION |
| 04th Apr 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 15th Mar 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 01st Mar 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 28th Feb 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
